Preventive effect of monascus-fermented products enriched with ubiquinones on type 2 diabetic rats induced by a high-fructose plus high-fat diet

Journal of Medicinal Food

Volumn 17, Issue 7, 2014, Pages 826-829

  Pyo, Young Hee ^a   Lee, Kyung Won ^b  

^a Sungshin Women's University   (South Korea)

^b Dept of Food Eng   (South Korea)

Author keywords

antioxidant enzymes; atorvastatin; coenzyme Qs; hyperglycemia; insulin sensitivity; Monascusfermented grains

Indexed keywords

ATORVASTATIN; CATALASE; FRUCTOSE; GLUCOSE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; UBIQUINONE; ANTIOXIDANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; FERMENTED PRODUCT; GLUCOSE BLOOD LEVEL; GRAIN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; MALE; MONASCUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PEROXIDATION; PRIORITY JOURNAL; RAT; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; FERMENTATION; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; FERMENTATION; FRUCTOSE; GLUTATHIONE PEROXIDASE; INSULIN RESISTANCE; MALE; MONASCUS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; UBIQUINONE;

EID: 84904327103     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.3001     Document Type: Article

References (24)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. (Pubitemid 38579764)
2. DeFronzo RA: Pharmacologic therapy for type 2 diabetes mel-litus. Ann Intern Med 1999;131:281-303.
3. Ademiluyi A, Oboh G: Aqueous extracts of roselle (Hibiscus sabdariffa Linn.) varieties inhibit a-amylase and a-glucosidase activities in vitro. J Med Food 2013;16:88-93.
4. Bray GA, Nielsen SJ, Popkin BM: Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537-543. (Pubitemid 41103894)
5. Samuel VT. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metabol 2011;22:60-65.
6. Reddy SS, Ramatholisamma P, Karuna R, Saralakumari D: Preventive effect of Tinospora cordifolia against high-fructose diet-induced insulin resistance and oxidative stress in male Wistar rats. Food Chem Toxicol 2009;47:2224-2229.
7. Journoud M, Jones PJ: Red yeast rice: a new hypolipidemic drug. Life Sci 2004;74:2675-2683. (Pubitemid 38396761)
8. Li CL, Zhu Y, Wang YY, Zhu JS, Chang J: Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res 1998;18:71-81. (Pubitemid 27528238)
9. Subhagar S, Aravindan R, Viruthagiri T: Statistical optimization of anticholesterolemic drug lovastatin production by the red mold Monascus purpureus. Food Bioprod Proc 2010;88:266-276.
10. Pyo YH, Seong KS: Hypolipidemic effects of Monascus-fer-mented soybean extracts in rats fed a high-fat and -cholesterol diet. J Agric Food Chem 2009;57:8617-862.
11. 10 during treatment with HMG-CoA reductase inhibitors. Mol Asp Med 1997;18:137-144.
12. 10 levels in ICR mice. Br J Nutr 2005;93:131-135.
13. Ernster L, Dallner G: Biochemical, physiological, and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271:195-207.
14. Chamberlain LH: Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes. FEBS Lett 2001;507: 357-361. (Pubitemid 33030265)
15. Koh K, Quon M, Ha S: Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol 2010;55:1209-1216.
16. Kettawan A, Takahashi T, Kongkachuichai R, Charoenkiatkul S, Okamoto T: Protective effects of coenzyme Q10 on decreased oxidative stress resistance induced by simvastatin. J Clin Bio-chem Nutr 2007;40:194-202. (Pubitemid 46984212)
17. Pyo YH, Seong KS: Effects of Monascus-fermented grain extracts on plasma antioxidant status and tissue levels of ubiqui-nones and a-tocopherol in hyperlipidemic rats. Food Chem 2013;141:428-435.
18. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB: Homeostasis model assessment closely mirror the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57-63.
19. Colbert JD, Stone JA: Statin use and the risk of incident diabetes mellitus: a review of the literature. Can J Cardiol 2012;28:581-589.
20. Chidambaram J, Carani Venkatraman A: Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet. Food Chem Toxicol 2010;48:2021-2029.
21. King GL, Locken MR: Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004;122:333-338. (Pubitemid 39506591)
22. Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17: 24-38. (Pubitemid 36410972)
23. Bentinger M, Brismar K, Dallner G: The antioxidant role of coenzyme Q. Mitochondrion 2007;7:S41-S50. (Pubitemid 46712227)
24. Palomaki A, Malminiemi K, Metsa KT: Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment. FEBS Lett 1997;410:254-258. (Pubitemid 27304075)